Erzhi Pill® Repairs Experimental Liver Injury via TSC/mTOR Signaling Pathway Inhibiting Excessive Apoptosis
The present study aimed to investigate the mechanism of hepatoprotective effect of Erzhi Pill (EZP) on the liver injury via observing TSC/mTOR signaling pathway activation. The experimental liver injury was induced by 2-acetylaminofluorene (2-AAF) treatment combined with partial hepatectomy (PH). EZ...
Main Authors: | Bu-gao Zhou, Hai-mei Zhao, Xiu-yun Lu, Xin Wang, Yong Zou, Rong Xu, Hai-yang Yue, Yi Liu, Zheng-yun Zuo, Duan-yong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/5653643 |
Similar Items
-
Erzhi Pill® Protected Experimental Liver Injury Against Apoptosis via the PI3K/Akt/Raptor/Rictor Pathway
by: Hai-Mei Zhao, et al.
Published: (2018-03-01) -
The TSC-mTOR pathway regulates macrophage polarization
by: Byles, Vanessa, et al.
Published: (2015) -
Study on the mechanism of Erzhi Pill in the treatment of breast cancer based on network pharmacology
by: Yuan Fahu, et al.
Published: (2021-01-01) -
Effect of Puerarin Regulated mTOR Signaling Pathway in Experimental Liver Injury
by: Bu-Gao Zhou, et al.
Published: (2018-10-01) -
Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.
by: Evelyn M Mrozek, et al.
Published: (2021-01-01)